Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets

N.Y. Research Team Discovers How Antidepressants and Cocaine Interact with Brain Cell Targets

July 30, 2008

In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction.

Their breakthrough research, featured as the cover story in a recent issue of Molecular Cell, describes the precise molecular and biochemical structure of drug targets known as neurotransmitter-sodium symporters (NSSs), and how cells use them to enable neural signaling in the brain. A second study, published in the latest issue of Nature Neuroscience, pinpoints where the drug molecules bind in the neurotransmitter transporter - their target in the human nervous system.




"These findings are so clear and detailed at the level of molecular behavior that they will be most valuable to developing more effective therapies for mood disorders and neurologic and psychiatric diseases, and to direct effective treatments for drug addiction to cocaine and amphetamines," says co-lead author Dr. Harel Weinstein, Chairman and Maxwell M. Upson Professor of Physiology and Biophysics, and director of the HRH Prince Alwaleed Bin Talal Bin Abdulaziz Al-saud Institute for Computational Biomedicine at Weill Cornell Medical College. "This research may also open the door to the development of new therapies for dopamine-neurotransmitter disorders such as Parkinson's disease, schizophrenia, and anxiety and depression."

To make their observations, the research team led by Dr. Jonathan Javitch, senior author of the Molecular Cell study and contributing author to the Nature Neuroscience study, and professor of Psychiatry and Pharmacology in the Center for Molecular Recognition at Columbia University Medical Center, stabilized different structural states of the neurotransmitter-sodium-symporter molecule that relate to steps in its function. This allowed the team to study how substrates and inhibitors affect the transition between these different states, and thus to understand the way in which its function is accomplished.

"Crystallography had allowed the identification of only one structural form of the molecule, but our experiments and computations were able to identify how this form changes and thereby add an understanding of the functional role of the different forms that the molecule must adopt to accomplish transport activity," says Dr. Javitch.

The main surprise was the realization that two binding sites on the transporter molecule need to be filled simultaneously and cooperate in order for transport to be driven across the cell membrane. For these studies, the scientists used the crystal structure of a bacterial transporter that is very similar to human neurotransmitter transporters. They performed computer simulations to reveal the path of the transported molecules into cells. Laboratory experimentation was used to test the computational predictions and validate the researchers' inferences.

Together, these procedures revealed a finely-tuned process in which two sodium ions bind and stabilize the transporter molecule for the correct positioning of the two messenger molecules - one deep in the center of the protein, and the other closer to the entrance. Like a key engaging a lock mechanism, this second binding causes changes in the transporter throughout the structure, allowing one of the two sodium molecules to move inward, and then release the deeply bound messenger and its sodium partner into the cell.

In the bacterial transporter studied, antidepressant molecules bind in the outer one of two sites, and stop the transport mechanism, leaving the messenger molecule outside the cell.

The second team of researchers, involving a collaboration of the Weinstein and Javitch labs with colleagues in Denmark (the labs of Ulrik Gether and Claus Loland), found that in the human dopamine transporter cocaine binds in the deep site, unlike the antidepressant binding in the bacterial transporter. Therefore, the researchers conclude that anti-cocaine therapy will be more complicated, because interfering with cocaine binding also means interference with the binding of natural messengers.

"This finding might steer anti-cocaine therapy in a completely new direction," says Dr. Weinstein.

Molecular understanding at this level of structural and dynamic detail is rare in the world of drug development, the authors note. Only about 15 percent of all drugs have a known molecular method-of-action, even though the effects of these drugs within the body - after very stringent and controlled laboratory testing - are well understood pharmacologically.

Contributing authors to the Molecular Cell study include Dr. Lei Shi from Weill Cornell Medical College, who had a major role in the computational simulations; Dr. Matthias Quick from Columbia University Medical Center and the New York State Psychiatric Institute, who had a major role in the experimental component; and Dr. Yongfang Zhao from Columbia University Medical Center.

Lead authors of the Nature Neuroscience study are first author Dr. Thijs Beuming of Weill Cornell Medical College and senior authors Drs. Claus Loland and Ulrik Gether of The Panum Institute of the University of Copenhagen, Denmark. Additional co-authors include Drs. Julie Kniazeff, Marianne Bergmann and Klaudia Raniszewska of The Panum Institute of the University of Copenhagen; Drs. Lei Shi and Luis Gracia of Weill Cornell; and Dr. Amy Hauck Newman of the National Institute on Drug Abuse (NIDA).

The NIH supported these studies, and it is noteworthy that both the Molecular Cell and the Nature Neuroscience study share an NIH funding source, a Program Project grant awarded by the National Institute on Drug Abuse and directed by Dr. Weinstein, with Drs. Javitch and Gether each directing one of the projects. Additional support came from the Danish Medical Research Council, the Lundbeck Foundation, the Novo Nordisk Foundation and the Maersk Foundation - all in Europe.

Weill Cornell Medical College



Related Cocaine News Articles Cocaine News and Current Cocaine Events RSS Cocaine News and Current Cocaine Events RSS
Addiction treatment proves successful in animal weight loss study
Vigabatrin, a medication proposed as a potential treatment for drug addiction by scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, also leads to rapid weight loss and reduced food intake according to a new animal study from the same research group.

Cocaine-induced synaptic plasticity linked to persistent addictive behaviors
The persistent nature of addiction is its most devastating feature. Understanding the mechanism underlying this phenomenon is the key for designing efficient therapy. Two separate studies published by Cell Press is the August 14 issue of the journal Neuron identify specific cocaine-induced changes in dopamine (DA) neurons that play a pivotal role in behaviors associated with drug addiction.

Halting retrieval of drug-associated memories may prevent addiction relapse
Disrupting the brain's retrieval of drug-associated memories may prevent relapse in drug addiction, according to new research in the August 13 issue of The Journal of Neuroscience.

'Erasing' drug-associated memories may stop drug addiction relapses
'Erasing' drug-associated memories may prevent recovering drug abusers from relapsing, researchers at the University of Cambridge have discovered.

Research reveals why some smokers become addicted with their first cigarette
New research from The University of Western Ontario reveals how the brain processes the 'rewarding' and addictive properties of nicotine, providing a better understanding of why some people seemingly become hooked with their first smoke.

Treatment for cigarette, alcohol and drug use in pregnancy improves outcomes for mom and baby
Pregnant women who receive treatment for substance abuse early in their pregnancy can achieve the same health outcomes as pregnant women with no substance abuse, according to a Kaiser Permanente study published online in the Journal of Perinatology.

Study shows high rates, rising costs of alcohol/drug disorders in hospitalized patients
Fourteen percent of patients admitted to the hospital have alcohol/drug abuse and addiction (ADAA) disorders, costs for which have risen sharply in recent years, according to a study in the June issue of the Journal of Substance Abuse Treatment (JSAT).

Prenatal drug exposure linked to sleep problems in children
In the first study across time into late childhood of the effects of prenatal drug exposure on sleep, prenatal drug exposure is associated with greater sleep problems in children.

Research reveals molecular fingerprint of cocaine addiction
The first large-scale analysis of proteins in the brains of monkeys addicted to cocaine reveals new information on how long-term cocaine use changes the amount and activity of various proteins affecting brain function.

Researchers find first conclusive evidence of Alzheimer's-like brain tangles in nonhuman primates
Researchers at the Yerkes National Primate Research Center, Emory University, have discovered the first conclusive evidence of Alzheimer's-like neurofibrillary brain tangles in an aged nonhuman primate.
More Cocaine News Articles


The Night of the Gun: A Reporter Investigates the Darkest Story of his Life--His Own
by David Carr

Amazon Best of the Month, August 2008: In his fabulously entertaining The Kid Stays in the Picture, legendary Hollywood producer Robert Evans wrote: "There are three sides to every story: yours, mine, and the truth." David Carr's riveting debut memoir, The Night of the Gun, takes this theory to the extreme, as the New York Times reporter embarks on a three-year fact-finding mission to revisit his...



The Heroin Diaries: A Year in the Life of a Shattered Rock Star
by Nikki Sixx

In one of the most unique memoirs of addiction ever published, Mötley Crüe's Nikki Sixx shares mesmerizing diary entries from the year he spiraled out of control in a haze of heroin and cocaine, presented alongside riveting commentary from people who were there at the time, and from Nikki himself.When Mötley Crüe was at the height of its fame, there wasn't any drug Nikki Sixx wouldn't do. He...



Crank
by Ellen Hopkins

Ellen Hopkins's semi-autobiographical verse novel, Crank, reads like a Go Ask Alice for the 21st century. In it, she chronicles the turbulent and often disturbing relationship between Kristina, a character based on her own daughter, and the "monster," the highly addictive drug crystal meth, or "crank." Kristina is introduced to the drug while visiting her largely absent and ne'er-do-well father....



Dark Alliance: The CIA, the Contras, and the Crack Cocaine Explosion
by Gary Webb

In July 1995, San Jose Mercury-News reporter Gary Webb found the Big One--the blockbuster story every journalist secretly dreams about--without even looking for it. A simple phone call concerning an unexceptional pending drug trial turned into a massive conspiracy involving the Nicaraguan Contra rebels, L.A. and Bay Area crack cocaine dealers, and the Central Intelligence Agency. For several...



Doctor Dealer: The Rise and Fall of an All-American Boy and His Multimillion-Dollar Cocaine Empire
by Mark Bowden

Doctor Dealer is the story of Larry Lavin, a bright, charismatic young man who rose from his working-class upbringing to win a scholarship to a prestigious boarding school, earn Ivy League college and dental degrees, and buy his family a house in one of Philadelphia's most exclusive suburbs. But behind the facade of his success was a dark secret -- at every step of the way he was building the...



White Lines
by Tracy Brown

Jada left home at the age of sixteen, running from her own demons and the horrors of physical abuse inflicted by her mother's boyfriend. She partied hard, and life seemed good when she was with Born, the neighborhood kingpin whose name was synonymous with money, power, and respect. But all his love couldn't save her from a crack addiction. Jada goes from crack addict and prostitute to survivor...



Marching Powder: A True Story of Friendship, Cocaine, and South America's Strangest Jail
by Thomas McFadden, Rusty Young

Rusty Young was backpacking in South America when he heard about Thomas McFadden, a convicted English drug trafficker who ran tours inside Bolivia's notorious San Pedro prison. Intrigued, the young Australian journalisted went to La Paz and joined one of Thomas's illegal tours. They formed an instant friendship and then became partners in an attempt to record Thomas's experiences in the jail....



Cooked: From the Streets to the Stove, from Cocaine to Foie Gras
by Jeff Henderson



Broken: My Story of Addiction and Redemption
by William Cope Moyers, Katherine Ketcham

From rock bottom to recovery—the son of veteran broadcaster Bill Moyers chronicles his life- shattering battle with addiction and the hard-won fight for recovery William Cope Moyers has come a long, long way. In 1994, he lay on the floor of an Atlanta crack house. His father had put together a search party. His worried family waited at home where Moyers had left them when he embarked on yet...



BLOW: How a Small-Town Boy Made $100 Million with the Medellin Cocaine Cartel and Lost It All
by Bruce Porter

BLOW is the unlikely story of George Jung's roller coaster ride from middle-class high school football hero to the heart of Pable Escobar's Medellin cartel-- the largest importer of the United States cocaine supply in the 1980s. Jung's early business of flying marijuana into the United States from the mountains of Mexico took a dramatic turn when he met Carlos Lehder, a young Colombian car thief...

© 2008 BrightSurf.com